|
|
|
|
| LEADER |
02400nam a22002895i 4500 |
| 001 |
978-1-59259-144-2 |
| 005 |
20190619081640.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2001 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781592591442
|
| 024 |
7 |
|
|a 10.1385/1592591442
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Renal Cancer
|b Methods and Protocols /
|c edited by Jack H. Mydlo.
|
| 250 |
|
|
|a 1st ed. 2001.
|
| 260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2001.
|
| 300 |
|
|
|a XII, 403 p. 55 illus.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Methods in Molecular Medicine,
|v 53
|
| 505 |
0 |
|
|a Renal Cell Carcinoma -- Pathology of Kidney Tumors -- In Vitro Experimental Techniques -- Telomerase Assay in Renal Cancer -- Comparative Genomic Hybridization -- Analyzing the FHIT Gene by RT-PCR, Western Blotting, and Immunohistochemistry -- Detection of Apoptosis in Renal Cell Carcinoma -- Fluorescence In Situ Hybridization (FISH) to Metaphase and Interphase Chromosomes -- Polymerase Chain Reaction Detection of DNA Sequence Deletions -- Matrix Metalloproteinases and Their Inhibitors -- Purification of Growth Factor mRNA in Renal Tissues:bFGF-2, FGF-2, TGF?, and EGFR -- Laser-Capture Microdissection -- Expression of c-met and WT-1 -- Molecular Analysis of the von Hippel-Lindau Disease Gene -- Experimental Models and Methods in Antibody Targeting of Renal Cell Carcinoma -- In Vivo Experimental Techniques -- Orthotopic Model of Renal Cell Carcinoma -- Murine Animal Model -- Angiogenesis Assays -- Antiangiogenic Approaches to Renal Cell Carcinoma -- Clinical Trials and Experiments -- Interferon Alpha, GM-CSF-Activated T Cells, and IL-6 in Renal Cell Carcinoma -- Immunotherapeutic Approach to Cancer with Cutaneous DNA Vaccination -- Monoclonal Antibodies -- Treatment Strategies in Metastatic Renal Cell Carcinoma -- 23 Assessment of T-Cell Immune Dysfunction in Patients with Renal Cell Carcinoma -- Transforming Growth Factor-?1 as a Novel Marker of Response to Therapy for Renal Cell Carcinoma -- Static and Flow Cytometry.
|
| 650 |
|
0 |
|a Oncology .
|
| 650 |
1 |
4 |
|a Oncology.
|
| 700 |
1 |
|
|a Mydlo, Jack H.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1385/1592591442
|